HSPs can bind to antigenic peptides on the surface of cancer cells, forming HSP-peptide complexes, which facilitate the uptake, processing, and presentation of tumor-specific antigens, subsequently presented by antigen-presenting cells (APCs) to CD8+ cytotoxic T lymphocytes [32]. The gene discussed is CD8A; the disease is cancer.